The epigenetic factor KDM2B regulates cell adhesion, small rho GTPases, actin cytoskeleton and migration in prostate cancer cells

Research output: Contribution to journalJournal articleResearchpeer-review

  • Nefeli Zacharopoulou
  • Anna Tsapara
  • Galatea Kallergi
  • Evi Schmid
  • Philip N Tsichlis
  • Kampranis, Sotirios
  • Christos Stournaras

The histone demethylase KDM2B is an epigenetic factor with oncogenic properties that is regulated by the basic fibroblasts growth factor (FGF-2). It has recently been shown that KDM2B co-operates with Polycomb Group proteins to promote cell migration and angiogenesis in tumors. In the present study we addressed the role of KDM2B in regulating actin cytoskeleton signaling, cell-cell adhesion and migration of prostate tumor cells. We report here that KDM2B is functionally expressed in DU-145 prostate cancer cells, activated by FGF-2 and regulates EZH2. KDM2B knockdown induced potent up-regulation of gene transcription and protein expression of the epithelial markers E-cadherin and ZO-1, while KDM2B overexpression down-regulated the levels of both markers, suggesting control of cell adhesion by KDM2B. RhoA and RhoB protein expression and activity were diminished upon KDM2B-knockdown and upregulated in KDM2B-overexpressing cell clones. In accordance, actin reorganization with formation of stress fibers became evident in KDM2B-overexpressing cells and abolished in the presence of the Rho inhibitor C3 transferase. DU-145 cell migration was significantly enhanced in KDM2B overexpressing cells and abolished in C3-pretreated cells. Conversely, the retardation of cell migration observed in KDM2B knockdown cells was enhanced in C3-pretreated cells. These results establish a clear functional link between the epigenetic factor KDM2B and the regulation of cell adhesion and Rho-GTPases signaling that controls actin reorganization and cell migration.

Original languageEnglish
JournalB B A - Molecular Cell Research
Volume1865
Issue number4
Pages (from-to)587-597
Number of pages11
ISSN0167-4889
DOIs
Publication statusPublished - 2018
Externally publishedYes

Bibliographical note

Copyright © 2018 Elsevier B.V. All rights reserved.

    Research areas

  • Actin Cytoskeleton/metabolism, Biomarkers, Tumor/metabolism, Cadherins/metabolism, Cell Adhesion/genetics, Cell Line, Tumor, Cell Movement/genetics, Enhancer of Zeste Homolog 2 Protein/metabolism, Epigenesis, Genetic, F-Box Proteins/genetics, Gene Expression Regulation, Neoplastic, HEK293 Cells, Humans, Jumonji Domain-Containing Histone Demethylases/genetics, Male, Models, Biological, Prostatic Neoplasms/genetics, Zonula Occludens-1 Protein/metabolism, rho GTP-Binding Proteins/metabolism

ID: 209366850